Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

87 Results

Guidelines and Advice

Treatment of Acute Myeloid Leukemia in Older Patients

Status: Archived
ID: 6-14

Dec 2008

Guidelines and Advice

Guidance on the Substitution of Systemic Therapy Agents

Status: Current
ID: GL-C50-33
Version: 1

Aug 2017

Guidelines and Advice

Recommendations for the Safe Use and Handling of Oral Anti-Cancer Drugs (OACDs) in Community Pharmacy: A Pan-Canadian Consensus Guideline

Status: Current
ID: GL-C50-30

Feb 2017

Guidelines and Advice

Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update

Status: Current
ID: GL-7-A-2016-3

Apr 2017

Guidelines and Advice

Use of Preoperative Chemotherapy With or Without Postoperative Radiotherapy in Technically Resectable Stage IIIA Non-Small Cell Lung Cancer

Status: Archived
ID: 7-4
Version: 2

Dec 2017

Cancer facts

Reported Tobacco Screening Increases among New Cancer Patients

Jan 2017

Cancer facts

Cancer rates increasing among children in Ontario

Nov 2017

Cancer facts

Ontario Cancer Profiles Lets You Explore Cancer Statistics

Aug 2017

Guidelines and Advice

Models of Care for Cancer Survivorship

Status: Current
ID: 26-1
Version: 2

Mar 2017

Guidelines and Advice

Follow-up After Primary Therapy for Endometrial Cancer

Status: Current
ID: 4-9
Version: 2

Jun 2017

Guidelines and Advice

The Use of Epidermal Growth Factor Receptor Inhibitors in Advanced Colorectal Cancer

Status: Archived
ID: CED 8

Jul 2008

Guidelines and Advice

The Use of Imatinib Mesylate (GleevecTM) in Patients with Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Status: Archived
ID: CED 10

Sep 2008

Pages